Dr. Achilles Paparsenos, MD (he/him) is an Endocrinologist in Yardley, PA with over 15 years of experience. What is your opinion of Dr. Achilles Paparsenos, MD? Rate this provider below so other people can make informed decision.
Over 15 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Achilles Paparsenos, MD has received over $44,204 which includes payments from the following companies:
$31,555.04 from LILLY USA, LLC
$3,014.21 from Novo Nordisk Inc
$2,343.32 from sanofi-aventis U.S. LLC
$913.84 from Merck Sharp & Dohme Corporation
$851.54 from AstraZeneca Pharmaceuticals LP
$728.86 from Janssen Pharmaceuticals, Inc
$369.69 from Amgen Inc.
$355.82 from Medtronic MiniMed, Inc.
$319.60 from Becton, Dickinson and Company
$313.86 from Tandem Diabetes Care, Inc.
$308.56 from INSULET CORPORATION
$299.19 from Boehringer Ingelheim Pharmaceuticals, Inc.
$259.14 from MannKind Corporation
$254.01 from GlaxoSmithKline, LLC.
$179.90 from GENZYME CORPORATION
$170.68 from Gemini Laboratories, LLC
$161.89 from Takeda Pharmaceuticals America, Inc.
$160.65 from TherapeuticsMD, Inc.
$147.98 from AbbVie, Inc.
$138.84 from Abbott Laboratories
Payments received by Dr. Achilles Paparsenos, MD were from the following categories:
$23,691.89 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!